Cargando…

3D Imaging Detection of HER2 Based in the Use of Novel Affibody-Quantum Dots Probes and Ratiometric Analysis

Patients with breast cancer (BC) overexpressing HER2 (HER2+) are selected for Trastuzumab treatment, which blocks HER2 and improves cancer prognosis. However, HER2+ diagnosis, by the gold standard, immunohistochemistry, could lead to errors, associated to: a) variability in sample manipulation (thin...

Descripción completa

Detalles Bibliográficos
Autores principales: Pérez-Treviño, Perla, la Cerda, Héctor Hernández-De, Pérez-Treviño, Jorge, Fajardo-Ramírez, Oscar Raúl, García, Noemí, Altamirano, Julio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053773/
https://www.ncbi.nlm.nih.gov/pubmed/29627705
http://dx.doi.org/10.1016/j.tranon.2018.03.004
_version_ 1783340888066359296
author Pérez-Treviño, Perla
la Cerda, Héctor Hernández-De
Pérez-Treviño, Jorge
Fajardo-Ramírez, Oscar Raúl
García, Noemí
Altamirano, Julio
author_facet Pérez-Treviño, Perla
la Cerda, Héctor Hernández-De
Pérez-Treviño, Jorge
Fajardo-Ramírez, Oscar Raúl
García, Noemí
Altamirano, Julio
author_sort Pérez-Treviño, Perla
collection PubMed
description Patients with breast cancer (BC) overexpressing HER2 (HER2+) are selected for Trastuzumab treatment, which blocks HER2 and improves cancer prognosis. However, HER2+ diagnosis, by the gold standard, immunohistochemistry, could lead to errors, associated to: a) variability in sample manipulation (thin 2D sections), b) use of subjective algorithms, and c) heterogeneity of HER2 expression within the tissue. Therefore, we explored HER2 3D detection by multiplexed imaging of Affibody-Quantum Dots conjugates (Aff-QD), ratiometric analysis (RMA(FI)) and thresholding, using BC multicellular tumor spheroids (BC-MTS) (~120 μm of diameter) as 3D model of BC. HER2+, HER2– and hybrid HER2+/− BC-MTS (mimicking heterogeneous tissue) were incubated simultaneously with two Aff-QD probes (anti-HER2 and negative control (NC), respectively, (1:1)). Confocal XY sections were recorded along the Z distance, and processed by automatized RMA(FI) (anti-HER2 Aff-QD/ NC). Quantifying the NC fluorescence allowed to predict the fraction of non-specific accumulation of the anti-HER2 probe within the thick sample, and resolve the specific HER2 level. HER2 was detected up to 30 μm within intact BC-MTS, however, permeabilization improved detection up to 70 μm. Specific HER2 signal was objectively quantified, and HER2 3D-density of 9.2, 48.3 and 30.8% were obtained in HER2−, HER2+ and hybrid HER2+/− permeabilized BC-MTS, respectively. Therefore, by combining the multiplexing capacity of Aff-QD probes and RMA(FI), we overcame the challenge of non-specific probe accumulation in 3D samples with minimal processing, yielding a fast, specific spatial HER2 detection and objective quantification.
format Online
Article
Text
id pubmed-6053773
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Neoplasia Press
record_format MEDLINE/PubMed
spelling pubmed-60537732018-07-24 3D Imaging Detection of HER2 Based in the Use of Novel Affibody-Quantum Dots Probes and Ratiometric Analysis Pérez-Treviño, Perla la Cerda, Héctor Hernández-De Pérez-Treviño, Jorge Fajardo-Ramírez, Oscar Raúl García, Noemí Altamirano, Julio Transl Oncol Original article Patients with breast cancer (BC) overexpressing HER2 (HER2+) are selected for Trastuzumab treatment, which blocks HER2 and improves cancer prognosis. However, HER2+ diagnosis, by the gold standard, immunohistochemistry, could lead to errors, associated to: a) variability in sample manipulation (thin 2D sections), b) use of subjective algorithms, and c) heterogeneity of HER2 expression within the tissue. Therefore, we explored HER2 3D detection by multiplexed imaging of Affibody-Quantum Dots conjugates (Aff-QD), ratiometric analysis (RMA(FI)) and thresholding, using BC multicellular tumor spheroids (BC-MTS) (~120 μm of diameter) as 3D model of BC. HER2+, HER2– and hybrid HER2+/− BC-MTS (mimicking heterogeneous tissue) were incubated simultaneously with two Aff-QD probes (anti-HER2 and negative control (NC), respectively, (1:1)). Confocal XY sections were recorded along the Z distance, and processed by automatized RMA(FI) (anti-HER2 Aff-QD/ NC). Quantifying the NC fluorescence allowed to predict the fraction of non-specific accumulation of the anti-HER2 probe within the thick sample, and resolve the specific HER2 level. HER2 was detected up to 30 μm within intact BC-MTS, however, permeabilization improved detection up to 70 μm. Specific HER2 signal was objectively quantified, and HER2 3D-density of 9.2, 48.3 and 30.8% were obtained in HER2−, HER2+ and hybrid HER2+/− permeabilized BC-MTS, respectively. Therefore, by combining the multiplexing capacity of Aff-QD probes and RMA(FI), we overcame the challenge of non-specific probe accumulation in 3D samples with minimal processing, yielding a fast, specific spatial HER2 detection and objective quantification. Neoplasia Press 2018-04-05 /pmc/articles/PMC6053773/ /pubmed/29627705 http://dx.doi.org/10.1016/j.tranon.2018.03.004 Text en © 2018 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original article
Pérez-Treviño, Perla
la Cerda, Héctor Hernández-De
Pérez-Treviño, Jorge
Fajardo-Ramírez, Oscar Raúl
García, Noemí
Altamirano, Julio
3D Imaging Detection of HER2 Based in the Use of Novel Affibody-Quantum Dots Probes and Ratiometric Analysis
title 3D Imaging Detection of HER2 Based in the Use of Novel Affibody-Quantum Dots Probes and Ratiometric Analysis
title_full 3D Imaging Detection of HER2 Based in the Use of Novel Affibody-Quantum Dots Probes and Ratiometric Analysis
title_fullStr 3D Imaging Detection of HER2 Based in the Use of Novel Affibody-Quantum Dots Probes and Ratiometric Analysis
title_full_unstemmed 3D Imaging Detection of HER2 Based in the Use of Novel Affibody-Quantum Dots Probes and Ratiometric Analysis
title_short 3D Imaging Detection of HER2 Based in the Use of Novel Affibody-Quantum Dots Probes and Ratiometric Analysis
title_sort 3d imaging detection of her2 based in the use of novel affibody-quantum dots probes and ratiometric analysis
topic Original article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053773/
https://www.ncbi.nlm.nih.gov/pubmed/29627705
http://dx.doi.org/10.1016/j.tranon.2018.03.004
work_keys_str_mv AT pereztrevinoperla 3dimagingdetectionofher2basedintheuseofnovelaffibodyquantumdotsprobesandratiometricanalysis
AT lacerdahectorhernandezde 3dimagingdetectionofher2basedintheuseofnovelaffibodyquantumdotsprobesandratiometricanalysis
AT pereztrevinojorge 3dimagingdetectionofher2basedintheuseofnovelaffibodyquantumdotsprobesandratiometricanalysis
AT fajardoramirezoscarraul 3dimagingdetectionofher2basedintheuseofnovelaffibodyquantumdotsprobesandratiometricanalysis
AT garcianoemi 3dimagingdetectionofher2basedintheuseofnovelaffibodyquantumdotsprobesandratiometricanalysis
AT altamiranojulio 3dimagingdetectionofher2basedintheuseofnovelaffibodyquantumdotsprobesandratiometricanalysis